Date: 2015-05-30
Type of information: Nomination
Compound: director of product development, chief technology officer
Company: Poietis (France)
Therapeutic area: Technology - Services
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On March 30, 2015, Poietis, a bioprinting company, announced the reinforcement of its management team with the recruitment of two executives integrating its management board.
- Delphine Fayol is appointed Director of Product Development. Delphine is an engineer from Ecole Polytechnique and holds a PhD from the University Paris 7 in the field of tissue engineering. Before joining Poietis, Delphine worked at Bertin Technologies on industrialization projects of stem cell culture processes for autologous cardiac therapy. She also attended the Ignite Stanford entrepreneurship program from Stanford Business School.
- Bertrand Viellerobe is appointed Chief Technical Officer. Bertrand has a doctorate in physics from the University of Bordeaux and has 17 years of experience in the photonics field. He worked 10 years at Mauna Kea Technologies (fiber-based confocal imaging for clinical applications) as R & D manager, before joining the cluster Route des Lasers® in Bordeaux as Project Director. Bertrand is co-author of 25 articles and co-inventor of 13 patents.
Financial terms:
Latest news:
Is general: Yes
